Jan Booij

Molecular imaging, with special interest in neuropsychiatric disorders

Focus of research:

Our research is focused on neuroreceptor imaging with SPECT and PET, with special interests in Parkinson’s disease, dementia with Lewy bodies, schizophrenia, addiction, major depression, and neurotoxicity of XTC. In addiction, preclinial research is focussed on the development of new SPECT and PET tracers, and SPECT imaging in small laboratory animals.

AMC themes: Neurological & Psychiatric Disorders
Departments: Nuclear Medicine


Claudia Vingerhoets

Clinical and neurobiological characterisation of “muscarinic receptor- deficit schizophrenia MRDS”

Read more →

Eline Zaaijer

Feasibility, mechanism of action and potential side effects of extended release depot naltrexone in opioid dependent patients

Read more →

Erik Boot

Phenylketonuria: dopamine transmission and relationship with phenylalanine levels and cognitive performance in adults – a pilot study

Read more →

Esther D.A. van Duin

“Biological markers for psychiatric disorders in 22q11 copy number variation syndromes.”

Read more →

Evelien Zoons

Dopamine-serotonin dysbalans in dystonia

Read more →

Geor Bakker

Clinical and neurobiological characterisation of “muscarinic receptor- deficit schizophrenia MRDS”

Read more →

Martin Gevonden

Effect of social exclusion on dopamine function in the human brain. A SPECT study in young adults with serious hearing impairment.

Read more →

Niels Schoenmaker

Post-delirium Cognitive Impairment

Read more →

Key publications:

Visser I , Lavini C, Booij J, Reneman L, Majoie C, de Boer AGEM, Wekking EM, de Joode EA, Van der Laan G , van Dijk FJH, Schene AH, den Heeten GJ, Cerebral impairment in chronic solvent-induced encephalopathy. ANN NEUROL 2008;63 (5):572-580

McKeith I, O’Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, Padovani A, Giubbini R, Bonuccelli U, Volterrani D, Holmes C, Kemp P, Tabet N, Meyer I, Reininger C, Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. LANCET NEUROL 2007;6 (4):305-313

Vastenhouw B, van der Have F, van der Linden AJA, von Oerthel L, Booij J, Burbach JPH, Smidt MP, Beekman FJ, Movies of dopamine transporter occupancy with ultra-high resolution focusing pinhole SPECT. MOL PSYCHIATR 2007;12 (11):984-987

de Win MML, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, den Heeten GJ, van den Brink W, Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. BRAIN 2008;131 (Part 11):2936-2945

Ruhé HG , Booij J, Weert HCV, Reitsma JB, Fransen EJF, Michel MC, Schene AH, Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial With Assessment of Serotonin Transporter Occupancy. NEUROPSYCHOPHARMACOL 2009;34 (4):999-1010